Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at almost $5 billion. The consumer ...
After protracted speculation, Bristol-Myers Squibb has confirmed it plans to divest its French over-the-counter (OTC) medicines business UPSA to Japan’s Taisho Pharma in a $1.6 billion deal.
ISE, Mie Prefecture--Recently discovered film footage from the Taisho Era (1912-1926 ... is now being shown at the Museum of Shinto and Japanese Culture on the university’s campus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback